The emerging therapy of this peptide represents a exciting advance in the care of the condition. Unlike existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and glucose-dependent https://tirzepatidepeptide022569.win-blog.com/23402679/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment